4//SEC Filing
Fawell Stephen 4
Accession 0001662579-24-000072
CIK 0001662579other
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 4:52 PM ET
Size
5.4 KB
Accession
0001662579-24-000072
Insider Transaction Report
Form 4
Fawell Stephen
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-08-29+65,000→ 65,000 totalExercise: $6.43Exp: 2034-08-28→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]33% of the shares underlying this option shall vest and become exercisable on August 29, 2025, with the remainder vesting in eight equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
C4 Therapeutics, Inc.
CIK 0001662579
Entity typeother
Related Parties
1- filerCIK 0002033387
Filing Metadata
- Form type
- 4
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 4:52 PM ET
- Size
- 5.4 KB